Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,269 | 251 | 90.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $440.00 | 5 | 9.3% |
| Education | $25.03 | 3 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $582.04 | 26 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $500.28 | 31 | $0 (2024) |
| Novo Nordisk Inc | $499.81 | 29 | $0 (2024) |
| Gilead Sciences, Inc. | $491.08 | 27 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $455.87 | 26 | $0 (2024) |
| Amgen Inc. | $313.19 | 19 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $236.85 | 19 | $0 (2019) |
| Bayer Healthcare Pharmaceuticals Inc. | $222.65 | 13 | $0 (2024) |
| Lilly USA, LLC | $195.71 | 11 | $0 (2024) |
| GlaxoSmithKline, LLC. | $187.23 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $556.13 | 28 | AstraZeneca Pharmaceuticals LP ($155.39) |
| 2023 | $483.54 | 26 | Bayer Healthcare Pharmaceuticals Inc. ($144.74) |
| 2022 | $420.30 | 22 | Gilead Sciences, Inc. ($137.86) |
| 2021 | $510.47 | 23 | Optos, Inc. ($115.96) |
| 2020 | $1,092 | 52 | SANOFI-AVENTIS U.S. LLC ($317.19) |
| 2019 | $734.92 | 44 | Gilead Sciences, Inc. ($138.18) |
| 2018 | $465.43 | 31 | SANOFI-AVENTIS U.S. LLC ($147.05) |
| 2017 | $471.41 | 33 | Janssen Pharmaceuticals, Inc ($128.45) |
All Payment Transactions
259 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Inflammation | ||||||
| 12/10/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $48.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/05/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Respiratory | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Respiratory | ||||||
| 10/01/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.89 | General |
| 09/09/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 09/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: RESPIRATORY | ||||||
| 08/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: DIABETES | ||||||
| 08/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Respiratory | ||||||
| 08/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Diabetes | ||||||
| 08/06/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.95 | General |
| 07/31/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Cardio-renal | ||||||
| 07/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: DIABETES | ||||||
| 07/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: Respiratory | ||||||
| 06/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Diabetes Care | ||||||
| 05/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Respiratory | ||||||
| 04/23/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $22.50 | General |
| Category: Narcoplepsy | ||||||
| 04/02/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.19 | General |
| 03/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: Respiratory | ||||||
| 03/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Respiratory | ||||||
| 02/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: RESPIRATORY | ||||||
| 02/21/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 02/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 1,676 | 2,714 | $270,307 | $89,250 |
| 2022 | 30 | 2,266 | 3,760 | $367,565 | $121,276 |
| 2021 | 41 | 3,422 | 5,291 | $466,813 | $139,386 |
| 2020 | 50 | 4,503 | 7,010 | $655,400 | $154,691 |
All Medicare Procedures & Services
148 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 152 | 563 | $78,758 | $32,082 | 40.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 110 | 110 | $34,210 | $14,256 | 41.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 44 | 63 | $18,585 | $8,307 | 44.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 86 | $18,404 | $7,248 | 39.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 81 | 83 | $12,865 | $6,270 | 48.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 137 | 310 | $9,610 | $2,604 | 27.1% |
| 92100 | Multiple measurements of eye fluid pressure over an extended time period | Office | 2023 | 45 | 45 | $4,500 | $2,604 | 57.9% |
| 92552 | Test for hearing various pitches using earphone | Office | 2023 | 88 | 89 | $5,429 | $1,955 | 36.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 57 | 59 | $2,360 | $1,824 | 77.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 34 | 41 | $8,123 | $1,419 | 17.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 120 | 136 | $13,464 | $1,278 | 9.5% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2023 | 64 | 67 | $6,365 | $1,045 | 16.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 31 | 93 | $6,045 | $914.40 | 15.1% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2023 | 57 | 90 | $8,100 | $856.80 | 10.6% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 24 | 50 | $3,400 | $811.00 | 23.9% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 126 | 247 | $6,422 | $792.87 | 12.3% |
| 92587 | Placement of ear probe for computerized measurement of sound with interpretation and report | Office | 2023 | 55 | 56 | $8,120 | $750.14 | 9.2% |
| G0306 | Complete cbc, automated (hgb, hct, rbc, wbc, without platelet count) and automated wbc differential count | Office | 2023 | 70 | 84 | $4,536 | $639.24 | 14.1% |
| 90471 | Administration of vaccine | Office | 2023 | 38 | 39 | $1,833 | $608.65 | 33.2% |
| 97032 | Application of electrical stimulation with therapist present, each 15 minutes | Office | 2023 | 20 | 57 | $3,249 | $550.03 | 16.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 18 | 21 | $2,835 | $527.63 | 18.6% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2023 | 28 | 28 | $2,660 | $495.32 | 18.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 114 | 138 | $3,450 | $470.58 | 13.6% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 21 | 21 | $2,457 | $357.07 | 14.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 39 | 43 | $2,322 | $327.23 | 14.1% |
About Dr. Keith Lamy, M.D
Dr. Keith Lamy, M.D is a Family Medicine healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164430278.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Keith Lamy, M.D has received a total of $4,734 in payments from pharmaceutical and medical device companies, with $556.13 received in 2024. These payments were reported across 259 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($4,269).
As a Medicare-enrolled provider, Lamy has provided services to 11,867 Medicare beneficiaries, totaling 18,775 services with total Medicare billing of $504,602. Data is available for 4 years (2020–2023), covering 148 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Austin, TX
- Active Since 08/04/2006
- Last Updated 07/13/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1164430278
Products in Payments
- JARDIANCE (Drug) $511.81
- SOLIQUA 100/33 (Biological) $377.19
- FARXIGA (Drug) $240.63
- Ozempic (Drug) $226.13
- Kerendia (Drug) $222.65
- XARELTO (Drug) $171.59
- Aimovig (Biological) $146.28
- TOUJEO (Drug) $138.24
- AIRSUPRA (Drug) $136.27
- TRELEGY ELLIPTA (Drug) $131.73
- MYRBETRIQ (Drug) $117.59
- PANORAMIC OPHTHALMOSCOPE (Device) $115.96
- SOLIQUA 100/33 (Drug) $112.43
- SOLIQUA (Drug) $78.71
- Rybelsus (Drug) $73.73
- TRULICITY (Drug) $71.08
- Vascepa (Drug) $68.12
- Repatha (Biological) $66.33
- UBRELVY (Drug) $65.77
- SYMBICORT (Drug) $65.63
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Austin
Dr. Cynthia Brinson, M.d, M.D
Family Medicine — Payments: $533,082
Dr. David Wright, M.d, M.D
Family Medicine — Payments: $151,266
James Hahn, Md, MD
Family Medicine — Payments: $45,324
Rodolfo Alamia, Md, MD
Family Medicine — Payments: $44,627
Dr. Nomita Kim, Md, MD
Family Medicine — Payments: $39,549
Mr. Eric Perez, Fnp-C, FNP-C
Family Medicine — Payments: $32,768